差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 Maravai Life Sciences Inc. - MRVI CFD

14.09
0.91%
0.12
低: 14.09
高: 14.5
Market Trading Hours* (UTC) Opens on Wednesday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.12
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 14.22
開盤價* 14.48
1 年變化* -64.44%
日範圍* 14.09 - 14.5
52 周範圍 12.16-41.82
平均交易量（10 天） 1.38M
平均交易量（3 個月） 28.01M
市值 3.57B
市盈率 5.70
流通股 369.97M
收入 883.00M
EPS 2.49
股息（收益率 %） N/A
貝塔 -100.00K
下一個財報發布日期 May 3, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 20, 2023 14.22 0.34 2.45% 13.88 14.35 13.88
Mar 17, 2023 14.17 -0.51 -3.47% 14.68 14.68 13.91
Mar 16, 2023 14.75 -0.43 -2.83% 15.18 15.24 14.32
Mar 15, 2023 15.41 0.31 2.05% 15.10 15.49 14.91
Mar 14, 2023 15.37 0.20 1.32% 15.17 15.70 14.90
Mar 13, 2023 14.86 0.38 2.62% 14.48 15.47 14.20
Mar 10, 2023 14.63 -0.06 -0.41% 14.69 14.81 14.05
Mar 9, 2023 14.82 -0.65 -4.20% 15.47 15.73 14.75
Mar 8, 2023 15.47 0.29 1.91% 15.18 15.80 15.00
Mar 7, 2023 15.24 -0.22 -1.42% 15.46 15.74 15.24
Mar 6, 2023 15.65 -0.73 -4.46% 16.38 16.51 15.65
Mar 3, 2023 16.36 0.61 3.87% 15.75 16.54 15.52
Mar 2, 2023 15.64 0.96 6.54% 14.68 15.85 14.60
Mar 1, 2023 14.95 0.34 2.33% 14.61 14.97 14.39
Feb 28, 2023 14.71 0.54 3.81% 14.17 14.78 14.12
Feb 27, 2023 14.33 0.24 1.70% 14.09 14.70 14.09
Feb 24, 2023 14.25 -0.23 -1.59% 14.48 15.01 13.95
Feb 23, 2023 14.84 -0.57 -3.70% 15.41 16.34 14.01
Feb 22, 2023 13.78 0.40 2.99% 13.38 13.99 13.25
Feb 21, 2023 13.97 -0.40 -2.78% 14.37 14.55 13.48

Maravai Life Sciences Inc. Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018
總收入 799.24 284.098 143.14 123.833
收入 799.24 284.098 143.14 123.833
收入成本，共計 140.561 79.649 66.849 60.765
毛利 658.679 204.449 76.291 63.068
總營業費用 244.595 171.788 119.152 113.019
銷售/一般/行政費用，總計 100.064 94.245 40.354 33.194
研究與開發 9.319 1.704 3.627 4.499
Depreciation / Amortization 5.9 7.6 8 8
異常費用（收入） -11.249 -11.41 0 5.622
Other Operating Expenses, Total 0 0 0.322 0.939
營業收入 554.645 112.31 23.988 10.814
利息收入（費用），非經營淨值 -30.26 -30.74 -29.959 -27.399
其他，淨值 6.38 0.126 0.118 0.087
稅前淨收入 530.765 81.696 -5.853 -16.498
稅後淨收入 469.25 78.816 -5.201 -16.915
少數股東權益 -287.213 13.342 2.4 4.446
未計算非常項目前的淨收益 182.037 92.158 -2.801 -12.469
淨收入 182.037 92.158 -2.801 -12.469
Total Adjustments to Net Income -15.27 -5.68 -5.259
普通股股東可獲收益 (不含非經常性項目) 182.037 76.888 -8.481 -17.728
普通股股東可獲收益 (含非經常性項目) 182.037 76.888 -8.481 -17.728
攤薄淨收入 402.356 76.888 -8.481 -17.728
攤薄後加權平均股 257.803 257.621 257.621 257.621
扣除特別項目的每股攤薄盈利 1.56071 0.29845 -0.03292 -0.06881
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 1.52746 0.27165 -0.03292 -0.05463
攤薄調整 220.319
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 244.293 228.444 204.81 217.775 148.211
收入 244.293 228.444 204.81 217.775 148.211
收入成本，共計 40.032 40.633 32.047 37.513 31.391
毛利 204.261 187.811 172.763 180.262 116.82
總營業費用 77.135 77.359 47.937 63.53 57.022
銷售/一般/行政費用，總計 32.4 27.553 25.189 24.085 21.571
研究與開發 3.695 8.573 0.45 0.032 2.16
Depreciation / Amortization 0.8 0.6 1.5 1.9 1.9
異常費用（收入） 0.208 0 -11.249 0 0
營業收入 167.158 151.085 156.873 154.245 91.189
利息收入（費用），非經營淨值 -2.664 -4.433 -8.545 -8.512 -7.904
其他，淨值 2.347 -2.83 3.324 -0.003 5.889
稅前淨收入 166.841 143.822 151.652 145.73 89.174
稅後淨收入 146.86 126.244 132.81 134.344 75.465
少數股東權益 -79.998 -70.803 -78.536 -85.269 -52.363
未計算非常項目前的淨收益 66.862 55.441 54.274 49.075 23.102
淨收入 66.862 55.441 54.274 49.075 23.102
普通股股東可獲收益 (不含非經常性項目) 66.862 55.441 54.274 49.075 23.102
普通股股東可獲收益 (含非經常性項目) 66.862 55.441 54.274 49.075 23.102
攤薄淨收入 127.963 109.642 115.148 49.094 23.102
攤薄後加權平均股 255.287 257.815 258.028 112.28 96.673
扣除特別項目的每股攤薄盈利 0.50125 0.42527 0.44626 0.43724 0.23897
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 0.48959 0.42793 0.40691 0.44554 0.24698
Total Adjustments to Net Income 0 0
攤薄調整 61.101 54.201 60.874 0.019
Other Operating Expenses, Total 0
  • 年度
  • 每季度
2021 2020 2019 2018
流動資産總額 740.039 331.598 60.552 53.802
現金和短期投資 551.272 236.184 24.7 21.866
Cash 551.272 236.184 24.7 21.866
應收賬款總額，淨額 117.512 51.218 18.83 15.991
Accounts Receivable - Trade, Net 117.512 51.218 18.83 15.991
Total Inventory 51.557 33.301 14.202 14.308
Prepaid Expenses 19.698 10.895 2.82 1.637
Total Assets 1918.28 1270.69 577.796 539.676
Property/Plant/Equipment, Total - Net 95.427 101.305 94.311 42.578
Property/Plant/Equipment, Total - Gross 107.959 111.952 102.41 31.492
Accumulated Depreciation, Total -12.532 -10.647 -8.099 -4.289
Goodwill, Net 152.766 224.275 224.275 224.275
Intangibles, Net 117.571 177.656 197.853 218.127
Other Long Term Assets, Total 812.473 435.857 0.805 0.894
Total Current Liabilities 93.777 130.778 29.562 35.919
Accounts Payable 8.154 8.171 7.478 3.604
Accrued Expenses 29.34 29.014 16.515 11.147
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 6 6 2.5 2.5
Other Current Liabilities, Total 50.283 87.593 3.069 18.668
Total Liabilities 1602.78 1182.18 436.4 395.271
Total Long Term Debt 524.591 584.781 387.702 337.389
Long Term Debt 524.591 528.614 334.783 335.55
Capital Lease Obligations 0 56.167 52.919 1.839
Deferred Income Tax 0 8.609 14.697 15.856
Minority Interest 229.862 66.235 3.231 3.611
Other Liabilities, Total 754.547 391.777 1.208 2.496
Total Equity 315.499 88.511 141.396 144.405
Common Stock 2.552 2.576 183.91 182.809
Retained Earnings (Accumulated Deficit) 184.561 0.854 -42.381 -38.237
Other Equity, Total 0 -0.044 -0.133 -0.167
Total Liabilities & Shareholders’ Equity 1918.28 1270.69 577.796 539.676
Total Common Shares Outstanding 255.157 257.621 257.621 257.621
Additional Paid-In Capital 128.386 85.125
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 619.135 740.039 687.478 644.491 425.543
現金和短期投資 431.469 551.272 547.898 374.71 247.675
Cash 431.469 551.272 547.898 374.71 247.675
應收賬款總額，淨額 120.355 117.512 65.939 83.534 122.821
Accounts Receivable - Trade, Net 120.355 117.512 65.939 83.534 122.821
Total Inventory 51.409 51.557 56.246 47.781 47.129
Prepaid Expenses 15.902 19.698 17.395 13.432 7.918
Total Assets 2043.23 1918.28 1894.68 1601.25 1351.77
Property/Plant/Equipment, Total - Net 47.702 46.332 108.322 104.751 105.133
Goodwill, Net 283.535 152.766 152.766 152.766 224.275
Intangibles, Net 235.405 117.571 121.225 125.116 172.616
Other Long Term Assets, Total 857.453 861.568 824.892 574.123 424.201
Total Current Liabilities 86.675 93.777 114.352 164.773 165.252
Accounts Payable 10.384 8.154 8.917 11.704 9.806
Accrued Expenses 32.411 29.34 30.248 17.711 28.973
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 5.44 6 7.174 7.083 6
Other Current Liabilities, Total 38.44 50.283 68.013 128.275 120.473
Total Liabilities 1660.67 1602.78 1592.05 1407.33 1239.16
Total Long Term Debt 524.499 524.591 580.908 582.209 583.517
Long Term Debt 524.499 524.591 525.584 526.583 527.593
Capital Lease Obligations 0 55.324 55.626 55.924
Deferred Income Tax 0 0 0 8.571
Minority Interest 271.743 229.862 150.979 139.22 97.145
Other Liabilities, Total 777.754 754.547 745.807 521.124 384.672
Total Equity 382.559 315.499 302.637 193.921 112.611
Common Stock 2.552 2.552 2.576 2.576 2.576
Additional Paid-In Capital 128.584 128.386 172.611 118.208 85.976
Retained Earnings (Accumulated Deficit) 251.423 184.561 127.45 73.176 24.101
Other Equity, Total 0 0 -0.039 -0.042
Total Liabilities & Shareholders’ Equity 2043.23 1918.28 1894.68 1601.25 1351.77
Total Common Shares Outstanding 255.159 255.157 257.66 257.66 257.621
Other Current Assets, Total 125.034
  • 年度
  • 每季度
2021 2020 2019 2018
淨收入/起跑線 469.25 78.816 -5.201 -16.915
經營活動産生的現金 368.57 152.187 24.115 -0.186
經營活動産生的現金 6.413 5.517 3.81 2.225
Amortization 18.339 20.32 20.274 20.122
Deferred Taxes 46.904 -5.464 -1.159 0.317
非現金物品 4.295 17.105 4.101 9.906
Cash Taxes Paid 22.473 5.006 -0.802 -0.097
已付現金利息 27.234 28.916 28.728 25.678
營運資金的變化 -176.631 35.893 2.29 -15.841
投資活動産生的現金 105.655 6.068 -17.148 -3.451
資本支出 -14.85 -28.432 -17.148 -3.611
其他投資現金流量項目，總計 120.505 34.5 0 0.16
融資活動産生的現金 -159.049 53.212 -4.167 -9.167
融資現金流項目 -154.758 -444.983 -1.527 -64.595
債務的發行（退還），淨額 -6 196.924 -2.64 55.428
外彙效應 -0.088 0.017 0.034 -0.069
現金淨變化 315.088 211.484 2.834 -12.873
股票的發行（報廢），淨額 1.709 301.271
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 146.86 469.25 343.006 210.196 75.465
Cash From Operating Activities 162.304 368.57 310.403 204.297 38.326
Cash From Operating Activities 1.855 6.413 6.623 4.151 1.256
Amortization 5.527 18.339 14.685 10.081 5.041
Deferred Taxes 13.217 46.904 29.438 18.211 11.76
Non-Cash Items 3.083 4.295 -11.033 -0.133 -0.876
Cash Taxes Paid 0.914 22.473 -16.569 9.087 2.725
Cash Interest Paid 1.373 27.234 23.03 15.547 7.219
Changes in Working Capital -8.238 -176.631 -72.316 -38.209 -54.32
Cash From Investing Activities -241.584 105.655 111.317 -7.234 -2.784
Capital Expenditures -241.584 -14.85 -9.188 -7.782 -3.332
Other Investing Cash Flow Items, Total 0 120.505 120.505 0.548 0.548
Cash From Financing Activities -40.523 -159.049 -110.051 -58.55 -24.058
Financing Cash Flow Items -39.889 -154.758 -106.298 -56.203 -23.128
Issuance (Retirement) of Stock, Net 0.726 1.709 1.329 1.018 0.57
Issuance (Retirement) of Debt, Net -1.36 -6 -5.082 -3.365 -1.5
Foreign Exchange Effects 0 -0.088 0.045 0.013 0.007
Net Change in Cash -119.803 315.088 311.714 138.526 11.491
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
GTCR Golder Rauner, LLC Private Equity 16.4518 21681033 0 2022-12-31 LOW
MFS Investment Management Investment Advisor/Hedge Fund 9.7083 12794081 -1144811 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.8689 10369998 177381 2022-12-31 LOW
Thrivent Asset Management, LLC Investment Advisor 4.688 6178115 3618369 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.8294 5046639 8967 2022-12-31 LOW
Ownership Capital Investment Advisor 2.9231 3852228 -237098 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 2.5245 3326948 1804248 2022-12-31 HIGH
ClearBridge Investments, LLC Investment Advisor/Hedge Fund 2.4268 3198111 222376 2022-12-31 LOW
JP Morgan Asset Management Investment Advisor 2.2357 2946267 -19401 2022-12-31 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 2.0797 2740696 663660 2022-12-31 HIGH
Two Sigma Investments, LP Hedge Fund 2.0337 2680167 1683573 2022-12-31 HIGH
Millennium Management LLC Hedge Fund 1.9695 2595548 799274 2022-12-31 HIGH
Select Equity Group, L.P. Investment Advisor/Hedge Fund 1.9158 2524793 -8996782 2022-12-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.7874 2355518 -1542833 2022-12-31 LOW
Mackenzie Financial Corporation Investment Advisor/Hedge Fund 1.6096 2121161 2070193 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4853 1957399 1025670 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3721 1808189 53213 2022-12-31 LOW
Balyasny Asset Management LP Hedge Fund 1.348 1776511 724950 2022-12-31 HIGH
Citi Investment Research (US) Research Firm 1.3249 1746002 -219343 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.2752 1680522 12436 2022-12-31 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

10770 Wateridge Circle Suite 200
Suite 200
SAN DIEGO
CALIFORNIA 92121
US

收入報表

  • Annual
  • Quarterly

人們也觀看

US100

12,733.00 Price
+1.320% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 1.8

Gold

1,943.53 Price
-1.790% 1D Chg, %
多頭倉位隔夜費用 -0.0177%
空頭倉位隔夜費用 0.0095%
隔夜費時間 21:00 (UTC)
價差 0.33

Oil - Crude

69.43 Price
+2.290% 1D Chg, %
多頭倉位隔夜費用 -0.0194%
空頭倉位隔夜費用 -0.0026%
隔夜費時間 21:00 (UTC)
價差 0.03

XRP/USD

0.47 Price
+24.450% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00492

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易